hims fda warning letter compounded semaglutide 2025 & Hers Health (HIMS) Securities Class Action Lawsuit Update Hims & Hers' Woes Compound

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus

Indiana Universitys Richard DiMarchi has dedicated his career to developing cutting-edge pharmaceutical treatments to treat both conditions

Dietary supplements should be used as part of a healthy lifestyle and not as a substitute for a varied, balanced diet

The company's FAQ states that "PT-141 is FDA-approved for low sexual desire." This requires clarification: bremelanotide (marketed under the brand name Vyleesi) received FDA approval specifically as a subcutaneous injection for hypoactive sexual desire disorder (HSDD) in premenopausal women

You cannot force psoriasis to go into remission

We're still a long way from these medications being prescribed for addiction, but, anecdotally, people I've spoken to are already seeing their effects